Skip to main content
PBLS logo

Parabilis Medicines, Inc.

PBLSNASDAQHealthcareBiotechnology

$26.51Today:- (-)

As of Oct 27, 2026 close

Market cap
$766.36M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$22.66$42.49
Volume (live)
-
Avg. volume (3M)
1.39M

Parabilis Medicines, Inc. (PBLS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Parabilis Medicines, Inc. stock.

Analyst Consensus Rating

Investment consensus from 4 professional research analysts

Consensus Rating

Buy
Based on 4 unique analysts
Low Confidence∞:1 Buy/Sell

Average Price Target

$41.75
+57.49% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PBLS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Robert Burns
HC Wainwright
BuyInitiates
$40.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$45.00
Michael Schmidt
Guggenheim
BuyMaintains
$40.00
Charles Zhu
LifeSci Capital
BuyMaintains
$42.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PBLS?

The analyst consensus rating for PBLS is Buy, based on the latest ratings from 4 analysts over the last 90 days.

What is the average price target for PBLS?

The average 12-month price target for PBLS is $41.75, representing an upside of 57.5% from the Oct 27, 2026 close of $26.51.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.